10397-13-4 Purity
97%
If you have any other questions or need other size, please get a quote.
Specification
Reference: [1]Archiv der Pharmazie,2020,vol. 353
Reference: [1]Current Patent Assignee: UCB - WO2003/74516, 2003, A1
Location in patent: Page/Page column 21
[2]Current Patent Assignee: UCB - WO2004/46123, 2004, A1
Location in patent: Page 27
[3]Courtney, Stephen M.; Hay, Philip A.; Buck, Richard T.; Colville, Claire S.; Porter, David W.; Scopes, David I. C.; Pollard, Faye C.; Page, Martin J.; Bennett, James M.; Hircock, Margaret L.; McKenzie, Edward A.; Stubberfield, Colin R.; Turner, Paul R.
[Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 12, p. 3269 - 3273]
Reference: [1]Current Patent Assignee: YAOPU SHANGHAI PHARMA TECH - CN111606910, 2020, A
* For details of the synthesis route, please refer to the original source to ensure accuracy.